Related Experiment Video
Updated: Jan 22, 2026

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
Published on: December 17, 2019
T cell immunotherapy enhanced by designer biomaterials
Zachary S Dunn1, John Mac1, Pin Wang2
1Mork Family Department of of Chemical Engineering and Materials Science, University of Southern California, Los Angeles, CA, United States.
Biomaterials show promise for improving T lymphocyte adoptive cellular transfer (ACT) cancer immunotherapy. These materials can enhance T cell expansion and reinfusion, addressing limitations in treating solid tumors and preventing relapse.
Area of Science:
- Oncology
- Immunology
- Biomedical Engineering
Background:
- Cancer immunotherapy, particularly T lymphocyte adoptive cellular transfer (ACT), has shown remarkable success in treating certain leukemias and lymphomas.
- However, ACT faces significant challenges when applied to solid tumors, including limited efficacy, toxicity, and cancer relapse.
- Biomaterials offer a potential solution to overcome these limitations in ACT.
Purpose of the Study:
- To review recent advancements in utilizing biomaterials to enhance T lymphocyte adoptive cellular cancer immunotherapy.
- To discuss the challenges and opportunities of employing biomaterials in both ex vivo T cell expansion and in vivo reinfusion stages of ACT.
Main Methods:
- Literature review of recent research on biomaterials in cancer immunotherapy.
- Analysis of biomaterial applications in T cell expansion and delivery for ACT.
- Discussion of current challenges and future directions in the field.
Main Results:
- Biomaterials can significantly improve the efficacy of T cell expansion ex vivo.
- Various biomaterial strategies are being developed to enhance T cell delivery and persistence in vivo.
- Addressing challenges in biomaterial design and application is crucial for successful ACT.
Conclusions:
- Biomaterials hold substantial promise for advancing T lymphocyte adoptive cellular immunotherapy for solid tumors.
- Further research and development are needed to optimize biomaterial-based strategies for improved clinical outcomes.
- Biomaterials represent a key innovation area for overcoming current limitations in ACT.
Related Concept Videos
Tumor Immunotherapy
Group Design
Factorial Design
Self-Evaluation: Self-Enhancement and Self-Verification
Design Example: Designing a Residential Plumbing System
Design Example: Designing Water Slide
Bernoulli's principle determines the water's velocity along the slide....

